- ANI Pharmaceuticals (ANIP +2.3%) acquires 31 previously marketed generic drug products from Teva Pharmaceuticals for $12.5M in cash and a % royalty of future gross profits.
- ANI will begin transferring the products to its manufacturing facilities immediately in anticipation of launches beginning in Q4.
- The acquisition expands ANI's generic portfolio significantly from its current 7 marketed products.
ANI acquires 31 generic products from Teva for $12.5M
Dec 26 2013, 16:44 ET